Gastroesophageal reflux disease and drugs of ingredients of chlorpheniramine maleate; pseudoephedrine hydrochloride - a phase IV clinical study of FDA data


Summary:

Gastroesophageal reflux disease is reported only by a few people who take drugs with ingredients of chlorpheniramine maleate; pseudoephedrine hydrochloride. This phase IV clinical study analyzes 171 people who have side effects while taking drugs with ingredients of chlorpheniramine maleate; pseudoephedrine hydrochloride from the the FDA. Among them, 2 have Gastroesophageal reflux disease. Find out below who they are, when they have Gastroesophageal reflux disease and more.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Codimal-l.a. 12, Isoclor, Pseudoephedrine hydrochloride and chlorpheniramine maleate.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Aug, 17, 2022

171 people reported to have side effects when taking drugs with ingredients of chlorpheniramine maleate; pseudoephedrine hydrochloride.
Among them, 2 people (1.17%) have Gastroesophageal reflux disease


What is Gastroesophageal reflux disease?

Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus) is found to be associated with 3,448 drugs and 3,029 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of chlorpheniramine maleate; pseudoephedrine hydrochloride cause Gastroesophageal reflux disease?

Gender of people who have Gastroesophageal reflux disease when taking drugs with ingredients of chlorpheniramine maleate; pseudoephedrine hydrochloride *:

  • female: 50 %
  • male: 50 %

Age of people who have Gastroesophageal reflux disease when taking drugs with ingredients of chlorpheniramine maleate; pseudoephedrine hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Conditions people have *:

  1. Type 2 Diabetes: 1 person, 50.00%
  2. Seasonal Allergy (allergic condition due to certain season): 1 person, 50.00%
  3. Osteoporosis (bones weak and more likely to break): 1 person, 50.00%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 50.00%
  5. Hypersensitivity: 1 person, 50.00%

Other drugs people take *:

  1. Zyrtec: 1 person, 50.00%
  2. Zocor: 1 person, 50.00%
  3. Zestril: 1 person, 50.00%
  4. Zantac: 1 person, 50.00%
  5. Vitamins: 1 person, 50.00%
  6. Levothroid: 1 person, 50.00%
  7. Hytrin: 1 person, 50.00%
  8. Glucophage: 1 person, 50.00%
  9. Fosamax: 1 person, 50.00%
  10. Cardizem Cd: 1 person, 50.00%

Other side effects people have besides Gastroesophageal reflux disease *:

  1. Weight Decreased: 1 person, 50.00%
  2. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 1 person, 50.00%
  3. Gait Disturbance: 1 person, 50.00%
  4. Fracture Nonunion (permanent failure of healing following a broken bone): 1 person, 50.00%
  5. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 50.00%
  6. Femur Fracture: 1 person, 50.00%
  7. Fall: 1 person, 50.00%
  8. Fainting (loss of consciousness and postural tone): 1 person, 50.00%
  9. Facial Bones Fracture (bone fracture of face): 1 person, 50.00%
  10. Dry Skin: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.


How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of chlorpheniramine maleate; pseudoephedrine hydrochloride, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on chlorpheniramine maleate; pseudoephedrine hydrochloride. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: